COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.
Georgia J McCaughanPietro R Di CiaccioMichelle Ananda-RajahNicole GilroyRaina MacIntyreBenjamin TehRobert WeinkoveJennifer CurnowJeffrey SzerAnoop K EnjetiDavid M RossStephen MulliganJudith TrotmanMichael J DickinsonHang QuachPhilip Young-Ill ChoiMark N PolizzottoConstantine S TamP Joy HoMatthew KuGareth GregoryShane GangatharanGregory HapgoodTara CochraneChan CheahSimon GibbsAndrew WeiAnna JohnstonMatthew GreenwoodH Miles PrinceMaya LatimerLeanne BerkahnJoel WightTasman ArmytageNada HamadPublished in: Internal medicine journal (2021)
Australia and New Zealand have achieved excellent community control of COVID-19 infection. In light of the imminent COVID-19 vaccination roll out in both countries, representatives from the Haematology Society of Australia and New Zealand and infectious diseases specialists have collaborated on this consensus position statement regarding COVID-19 vaccination in patients with haematological disorders. It is our recommendation that patients with haematological malignancies, and some benign haematological disorders, should have expedited access to high-efficacy COVID-19 vaccines, given that these patients are at high risk of morbidity and mortality from COVID-19 infection. Vaccination should not replace other public health measures in these patients, given that the effectiveness of COVID-19 vaccination, specifically in patients with haematological malignancies, is not known. Given the limited available data, prospective collection of safety and efficacy data of COVID-19 vaccination in this patient group is a priority.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- public health
- newly diagnosed
- ejection fraction
- chronic kidney disease
- randomized controlled trial
- prognostic factors
- healthcare
- peritoneal dialysis
- systematic review
- patient reported outcomes
- machine learning
- electronic health record
- artificial intelligence
- patient reported